T3+and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

Author(s):
Martijnse, I.S.; Dudink, R.L.; Kusters, M.; Vermeer, T.A.; West, N.P.; Nieuwenhuijzen, G.A.; Lijnschoten, I. van; Martijn, H.; Creemers, G.J.; Lemmens, V.E.; Velde, C.J. van de; Sebag-Montefiore, D.; Glynne-Jones, R.; Quirke, P.; Rutten, H.J.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-02-28
Language
English
Is part of
Annals of Surgical Oncology (2012), Vol. 19, no. 2, p. 392-401
hdl
1887/98624
doi
10.1245/s10434-011-1955-1